{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T01:01:50Z","timestamp":1781830910975,"version":"3.54.5"},"reference-count":43,"publisher":"Elsevier BV","issue":"32","license":[{"start":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T00:00:00Z","timestamp":1372636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"100 Talents\u2019 Program of Chinese Academy of Sciences, Shanghai PuJiang Career Development Award","award":["09PJ1411400"],"award-info":[{"award-number":["09PJ1411400"]}]},{"name":"973 Project","award":["2010CB912403"],"award-info":[{"award-number":["2010CB912403"]}]},{"DOI":"10.13039\/501100004826","name":"Beijing Natural Science Foundation","doi-asserted-by":"crossref","award":["7122129"],"award-info":[{"award-number":["7122129"]}],"id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004826","name":"Beijing Natural Science Foundation","doi-asserted-by":"crossref","award":["7112108"],"award-info":[{"award-number":["7112108"]}],"id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Science Foundation of China","doi-asserted-by":"crossref","award":["31270195"],"award-info":[{"award-number":["31270195"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Beijing Nova Program of Science and Technology","award":["2010B041"],"award-info":[{"award-number":["2010B041"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1016\/j.vaccine.2013.05.019","type":"journal-article","created":{"date-parts":[[2013,5,29]],"date-time":"2013-05-29T03:43:29Z","timestamp":1369799009000},"page":"3281-3287","source":"Crossref","is-referenced-by-count":84,"title":["Virus-like particles for enterovirus 71 produced from Saccharomyces cerevisiae potently elicits protective immune responses in mice"],"prefix":"10.1016","volume":"31","author":[{"given":"Hao-Yang","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-Feng","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-Feng","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.vaccine.2013.05.019_bib0005","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1017\/S0950268809991555","article-title":"Human enterovirus 71 and hand, foot and mouth disease","volume":"138","author":"Wong","year":"2010","journal-title":"Epidemiol Infect"},{"issue":"11","key":"10.1016\/j.vaccine.2013.05.019_bib0010","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/S1473-3099(10)70194-8","article-title":"Virology, epidemiology, pathogenesis, and control of enterovirus 71","volume":"10","author":"Solomon","year":"2010","journal-title":"Lancet Infect Dis"},{"issue":"7","key":"10.1016\/j.vaccine.2013.05.019_bib0015","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1086\/591462","article-title":"Acute chemokine response in the blood and cerebrospinal fluid of children with enterovirus 71-associated brainstem encephalitis","volume":"198","author":"Wang","year":"2008","journal-title":"J Infect Dis"},{"issue":"9","key":"10.1016\/j.vaccine.2013.05.019_bib0020","doi-asserted-by":"crossref","first-page":"e739","DOI":"10.1016\/j.ijid.2009.12.002","article-title":"Enterovirus 71 vaccine: close but still far","volume":"14","author":"Zhang","year":"2010","journal-title":"Int J Infect Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2013.05.019_bib0025","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1586\/erv.09.152","article-title":"Development of enterovirus 71 vaccines","volume":"9","author":"Lee","year":"2010","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2013.05.019_bib0030","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/1743-422X-7-116","article-title":"Producing infectious enterovirus type 71 in a rapid strategy","volume":"7","author":"Han","year":"2010","journal-title":"Virol J"},{"issue":"10","key":"10.1016\/j.vaccine.2013.05.019_bib0035","doi-asserted-by":"crossref","first-page":"3181","DOI":"10.1128\/JVI.61.10.3181-3189.1987","article-title":"Processing determinants required for in vitro cleavage of the poliovirus P1 precursor to capsid proteins","volume":"61","author":"Ypma-Wong","year":"1987","journal-title":"J Virol"},{"issue":"1","key":"10.1016\/j.vaccine.2013.05.019_bib0040","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/0042-6822(88)90172-9","article-title":"Protein 3CD is the major poliovirus proteinase responsible for cleavage of the P1 capsid precursor","volume":"166","author":"Ypma-Wong","year":"1988","journal-title":"Virology"},{"issue":"Pt 7","key":"10.1016\/j.vaccine.2013.05.019_bib0045","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1099\/0022-1317-69-7-1627","article-title":"Poliovirus protein 3CD is the active protease for processing of the precursor protein P1 in vitro","volume":"69","author":"Jore","year":"1988","journal-title":"J Gen Virol"},{"issue":"1","key":"10.1016\/j.vaccine.2013.05.019_bib0050","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/0042-6822(90)90502-I","article-title":"New evidence for the precursor role of 14 S subunits in poliovirus morphogenesis","volume":"177","author":"Rombaut","year":"1990","journal-title":"Virology"},{"issue":"3","key":"10.1016\/j.vaccine.2013.05.019_bib0055","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1128\/JVI.44.3.900-906.1982","article-title":"In vitro synthesis and assembly of picornaviral capsid intermediate structures","volume":"44","author":"Palmenberg","year":"1982","journal-title":"J Virol"},{"issue":"4","key":"10.1016\/j.vaccine.2013.05.019_bib0060","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/nsmb.2255","article-title":"A sensor-adaptor mechanism for enterovirus uncoating from structures of EV71","volume":"19","author":"Wang","year":"2012","journal-title":"Nat Struct Mol Biol"},{"issue":"12","key":"10.1016\/j.vaccine.2013.05.019_bib0065","doi-asserted-by":"crossref","first-page":"9743","DOI":"10.1128\/JVI.71.12.9743-9752.1997","article-title":"Dissecting the roles of VP0 cleavage and RNA packaging in picornavirus capsid stabilization: the structure of empty capsids of foot-and-mouth disease virus","volume":"71","author":"Curry","year":"1997","journal-title":"J Virol"},{"issue":"1","key":"10.1016\/j.vaccine.2013.05.019_bib0070","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1128\/JVI.69.1.13-22.1995","article-title":"RNA binding properties of poliovirus subviral particles","volume":"69","author":"Nugent","year":"1995","journal-title":"J Virol"},{"issue":"5","key":"10.1016\/j.vaccine.2013.05.019_bib0075","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1007\/s12275-012-2292-1","article-title":"The production and immunogenicity of human papillomavirus type 58 virus-like particles produced in Saccharomyces cerevisiae","volume":"50","author":"Kwag","year":"2012","journal-title":"J Microbiol"},{"key":"10.1016\/j.vaccine.2013.05.019_bib0080","article-title":"Viral nanoparticles and virus-like particles: platforms for contemporary vaccine design","author":"Plummer","year":"2010","journal-title":"Wiley Interdiscip Rev Nanomed Nanobiotechnol"},{"issue":"5","key":"10.1016\/j.vaccine.2013.05.019_bib0085","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S1470-2045(05)70101-7","article-title":"Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial","volume":"6","author":"Villa","year":"2005","journal-title":"Lancet Oncol"},{"issue":"2\u20133","key":"10.1016\/j.vaccine.2013.05.019_bib0090","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1159\/000050037","article-title":"HBV core particles as a carrier for B cell\/T cell epitopes","volume":"44","author":"Pumpens","year":"2001","journal-title":"Intervirology"},{"issue":"43","key":"10.1016\/j.vaccine.2013.05.019_bib0095","doi-asserted-by":"crossref","first-page":"6951","DOI":"10.1016\/j.vaccine.2010.08.052","article-title":"Enterovirus 71 virus-like particle vaccine: improved production conditions for enhanced yield","volume":"28","author":"Chung","year":"2010","journal-title":"Vaccine"},{"issue":"15","key":"10.1016\/j.vaccine.2013.05.019_bib0100","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1016\/j.vaccine.2008.01.058","article-title":"Immunization with virus-like particles of enterovirus 71 elicits potent immune responses and protects mice against lethal challenge","volume":"26","author":"Chung","year":"2008","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vaccine.2013.05.019_bib0105","doi-asserted-by":"crossref","first-page":"921","DOI":"10.3748\/wjg.v12.i6.921","article-title":"Expression, purification and characterization of enterovirus-71 virus-like particles","volume":"12","author":"Chung","year":"2006","journal-title":"World J Gastroenterol"},{"issue":"12","key":"10.1016\/j.vaccine.2013.05.019_bib0110","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1023\/A:1024071514438","article-title":"Formation of enterovirus-like particle aggregates by recombinant baculoviruses co-expressing P1 and 3CD in insect cells","volume":"25","author":"Hu","year":"2003","journal-title":"Biotechnol Lett"},{"key":"10.1016\/j.vaccine.2013.05.019_bib0115","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/1743-422X-8-106","article-title":"Antibody dependent enhancement infection of enterovirus 71 in vitro and in vivo","volume":"8","author":"Han","year":"2011","journal-title":"Virol J"},{"issue":"4","key":"10.1016\/j.vaccine.2013.05.019_bib0120","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.jcv.2011.05.002","article-title":"In vitro and in vivo characterization of a new enterovirus type 71-specific human intravenous immunoglobulin manufactured from selected plasma donors","volume":"51","author":"Cao","year":"2011","journal-title":"J Clin Virol"},{"issue":"5","key":"10.1016\/j.vaccine.2013.05.019_bib0125","doi-asserted-by":"crossref","first-page":"e20005","DOI":"10.1371\/journal.pone.0020005","article-title":"Purification and characterization of enterovirus 71 viral particles produced from vero cells grown in a serum-free microcarrier bioreactor system","volume":"6","author":"Liu","year":"2011","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.vaccine.2013.05.019_bib0130","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1007\/s10875-012-9690-3","article-title":"Analysis of the Th1\/Th2 reaction in the immune response induced by EV71 inactivated vaccine in neonatal rhesus monkeys","volume":"32","author":"Liang","year":"2012","journal-title":"J Clin Immunol"},{"issue":"17","key":"10.1016\/j.vaccine.2013.05.019_bib0135","doi-asserted-by":"crossref","first-page":"9386","DOI":"10.1128\/JVI.02856-06","article-title":"An attenuated strain of enterovirus 71 belonging to genotype a showed a broad spectrum of antigenicity with attenuated neurovirulence in cynomolgus monkeys","volume":"81","author":"Arita","year":"2007","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2013.05.019_bib0140","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1479-0556-5-6","article-title":"DNA vaccine constructs against enterovirus 71 elicit immune response in mice","volume":"5","author":"Tung","year":"2007","journal-title":"Genet Vaccines Ther"},{"key":"10.1016\/j.vaccine.2013.05.019_bib0145","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1146\/annurev.immunol.18.1.927","article-title":"DNA vaccines: immunology, application, and optimization*","volume":"18","author":"Gurunathan","year":"2000","journal-title":"Annu Rev Immunol"},{"issue":"11","key":"10.1016\/j.vaccine.2013.05.019_bib0150","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/j.micinf.2007.06.002","article-title":"Passive protection against lethal enterovirus 71 infection in newborn mice by neutralizing antibodies elicited by a synthetic peptide","volume":"9","author":"Foo","year":"2007","journal-title":"Microbes Infect"},{"issue":"1","key":"10.1016\/j.vaccine.2013.05.019_bib0155","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.virusres.2006.12.005","article-title":"Identification of neutralizing linear epitopes from the VP1 capsid protein of Enterovirus 71 using synthetic peptides","volume":"125","author":"Foo","year":"2007","journal-title":"Virus Res"},{"issue":"4","key":"10.1016\/j.vaccine.2013.05.019_bib0160","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1016\/j.bbrc.2009.09.103","article-title":"Generation of neutralizing monoclonal antibodies against Enterovirus 71 using synthetic peptides","volume":"390","author":"Li","year":"2009","journal-title":"Biochem Biophys Res Commun"},{"issue":"5\u20136","key":"10.1016\/j.vaccine.2013.05.019_bib0165","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/S0264-410X(01)00385-1","article-title":"Protection against lethal enterovirus 71 infection in newborn mice by passive immunization with subunit VP1 vaccines and inactivated virus","volume":"20","author":"Wu","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.05.019_bib0170","article-title":"Recombinant VP1 protein expressed in Pichia pastoris induces protective immune responses against EV71 in mice","author":"Wang","year":"2012","journal-title":"Biochem Biophys Res Commun"},{"issue":"9580","key":"10.1016\/j.vaccine.2013.05.019_bib0175","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1016\/S0140-6736(07)60946-5","article-title":"Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial","volume":"369","author":"Paavonen","year":"2007","journal-title":"Lancet"},{"issue":"23","key":"10.1016\/j.vaccine.2013.05.019_bib0180","doi-asserted-by":"crossref","first-page":"3483","DOI":"10.1016\/j.vaccine.2012.02.053","article-title":"Quantitative evaluation of the effect of the hepatitis B vaccine based on the HBsAg- and anti-HBs-positive rates in the Chinese population over the last 33 years","volume":"30","author":"Liu","year":"2012","journal-title":"Vaccine"},{"issue":"47","key":"10.1016\/j.vaccine.2013.05.019_bib0185","doi-asserted-by":"crossref","first-page":"6642","DOI":"10.1016\/j.vaccine.2012.08.071","article-title":"A virus-like particle vaccine for coxsackievirus A16 potently elicits neutralizing antibodies that protect mice against lethal challenge","volume":"30","author":"Liu","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.05.019_bib0190","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1475-2859-10-33","article-title":"Molecular and process design for rotavirus-like particle production in Saccharomyces cerevisiae","volume":"10","author":"Rodriguez-Limas","year":"2011","journal-title":"Microb Cell Fact"},{"issue":"7","key":"10.1016\/j.vaccine.2013.05.019_bib0195","doi-asserted-by":"crossref","first-page":"3067","DOI":"10.1128\/JVI.01779-10","article-title":"Sustained high levels of interleukin-6 contribute to the pathogenesis of enterovirus 71 in a neonate mouse model","volume":"85","author":"Khong","year":"2011","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2013.05.019_bib0200","article-title":"Immunogenicity and safety of an enterovirus 71 vaccine in healthy Chinese children and infants: a randomised, double-blind, placebo-controlled phase 2 clinical trial","author":"Zhu","year":"2013","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.vaccine.2013.05.019_bib0205","doi-asserted-by":"crossref","first-page":"e54451","DOI":"10.1371\/journal.pone.0054451","article-title":"Study of the integrated immune response induced by an inactivated EV71 vaccine","volume":"8","author":"Liu","year":"2013","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.vaccine.2013.05.019_bib0210","doi-asserted-by":"crossref","first-page":"e46043","DOI":"10.1371\/journal.pone.0046043","article-title":"Comparative analysis of the immunogenicity and protective effects of inactivated EV71 vaccines in mice","volume":"7","author":"Mao","year":"2012","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.vaccine.2013.05.019_bib0215","doi-asserted-by":"crossref","first-page":"e57601","DOI":"10.1371\/journal.pone.0057601","article-title":"Neutralizing antibodies induced by recombinant virus-like particles of enterovirus 71 genotype C4 inhibit infection at pre- and post-attachment steps","volume":"8","author":"Ku","year":"2013","journal-title":"PLoS One"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X13005975?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X13005975?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,7,27]],"date-time":"2020-07-27T07:24:04Z","timestamp":1595834644000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X13005975"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7]]},"references-count":43,"journal-issue":{"issue":"32","published-print":{"date-parts":[[2013,7]]}},"alternative-id":["S0264410X13005975"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2013.05.019","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,7]]}}}